“Prescription of Glucagon-Like Peptide 1 (GLP-1) in the Treatment of Patients With Type 2 Diabetes and Obesity: A Literature Review”. Revista Eletrônica Acervo Médico 11 (June 25, 2022): e10289. Accessed November 3, 2026. https://acervomais.com.br/medico/article/view/10289.